DrugsControl Media Services

News Detail

South Korea pharma Celltrion's Covid test gets US emergency use authorisation (27-10-2020)

SEOUL, 26 OCT 2020: South Korea's Celltrion Inc said on Monday it has received emergency use authorisation (EUA) from the USFood & Drug Administration (FDA) for its rapid Covid-19 testing kit Sampinute, which boosted shares of the company and its affiliates.

View Details

Source : The Times of India

Related News